Evidence map›Paper›PMID 37334097›Full record

ArticleProceedings (Baylor University. Medical Center)2023

July effect in clinical outcomes of esophagogastroduodenoscopy performed at teaching hospitals in the United States.

Karthik Gangu, Sanket Basida, Rehmat Ullah Awan, Mohammad Ali Butt, Austin Reed, Rao Afzal, Rahul Shekhar, Harleen Kaur Chela, Ebubekir S Daglilar, Abu Baker Sheikh

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Proceedings (Baylor University. Medical Center), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Karthik GanguDepartment of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas.
Sanket BasidaDepartment of Internal Medicine, University of Missouri System, Columbia, Missouri.
Rehmat Ullah AwanDepartment of Internal Medicine, Ochsner Rush Medical Center, Meridian, Mississippi.
Mohammad Ali ButtDepartment of Internal Medicine, Allegheny General Hospital - Western Pennsylvania Hospital Medical Education Consortium, Pittsburgh, Pennsylvania.ORCID https://orcid.org/0000-0002-1676-8511
Austin ReedDepartment of Internal Medicine, University of Missouri System, Columbia, Missouri.
Rao AfzalDepartment of Internal Medicine, University of Pittsburgh Medical Center Health System, Pittsburgh, Pennsylvania.
Rahul ShekharDepartment of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico.
Harleen Kaur ChelaDepartment of Internal Medicine, West Virginia University Health Sciences Center Charleston Division, Charleston, West Virginia.
Ebubekir S DaglilarDepartment of Internal Medicine, West Virginia University Health Sciences Center Charleston Division, Charleston, West Virginia.
Abu Baker SheikhDepartment of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico.
University of Missouri System · USUniversity of New Mexico · USWest Virginia University · USUniversity of Kansas Medical Center · USUPMC Health System · USWestern Pennsylvania Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Esophagogastroduodenoscopy (EGD) is a common procedure used for both diagnosis and treatment, but carries risks such as bleeding and perforation. The "July effect"-described as increased complication rates during the transition of new trainees-has been studied in other procedures, but has not been thoroughly evaluated for EGD. Methods: We used the National Inpatient Sample database for 2016 to 2018 to compare outcomes in EGD performed between July to September and April to June. Results: Approximately 0.91 million patients in the study received EGD between July to September (49.35%) and April to June (50.65%), with no significant differences between the two groups in terms of age, gender, race, income, or insurance status. Of the 911,235 patients, 19,280 died during the study period following EGD, 2.14% (July-September) vs 1.95% (April-June), with an adjusted odds ratio of 1.09 ( Conclusions: The results of this study are reassuring as the July effect on inpatient outcomes for EGDs was not significantly different according to our study. We recommend seeking prompt treatment and improving new trainee training and interspecialty communication for better patient outcomes.

Indexed as

Clinical outcomesesophagogastroduodenoscopyJuly effectNational Inpatient Sample

Identifiers

PMID37334097
PMCPMC10269412
OpenAlexW4375853177

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.